67Ga-PSMA I&T用于前列腺癌生化复发患者淋巴结转移的放射性引导手术
回顾性分析6例前列腺癌生化复发患者共7枚PSMA阳性淋巴结转移灶,术者于静脉注射院内合成的67Ga-PSMA I&T后24小时用γ探针行放射性引导手术。7枚淋巴结术中均获阳性γ信号,注射后22小时SPECT/CT在6例中4例检出5枚淋巴结;作者认为该方法是安全可行的选择。
要点
- 6例患者7枚PSMA阳性淋巴结转移灶中,术中γ探针全部7枚获阳性信号。
- 22小时SPECT/CT在6例中4例检出7枚中的5枚淋巴结。
- 淋巴结转移灶放射性蓄积为32.1 ± 15.1 kBq。
核心结论
- 作者认为使用67Ga-PSMA I&T的放射性引导手术对前列腺癌生化复发患者是安全且可行的选择。
- 作者指出67Ga-PSMA I&T按良好生产规范指南成功合成。
- 作者指出该放射性引导手术未给泌尿外科医生带来相关辐射负担,是核医学与泌尿外科的新型跨学科方法。
研究设计与样本
- 回顾性分析6例前列腺癌生化复发患者共7枚PSMA阳性淋巴结转移灶。
- 67Ga-PSMA I&T由院内合成,按德国药品法§13 2b静脉给药,注射后24小时用γ探针行放射性引导手术。
- 收集患者尿液样本,并进行职业与废弃物剂量学测量以描述辐射危害。
主要发现
- 67Ga-PSMA给药耐受良好,未出现不良反应。
- 22小时SPECT/CT在6例中4例检出7枚淋巴结中的5枚。
- 术中γ探针阳性信号识别出全部7枚淋巴结转移灶。
- 淋巴结转移灶中观察到67Ga的相关蓄积为32.1 ± 15.1 kBq。
- 近场淋巴结清扫的组织学分析发现的淋巴结转移灶多于PET/CT(及γ探针测量)所识别者。
临床怎么用
- 作者认为使用67Ga-PSMA I&T的放射性引导手术是前列腺癌生化复发患者安全且可行的选择。
- 作者指出该手术未给泌尿外科医生带来相关辐射负担。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Radioguided lymph node dissection in patients with prostate cancer, and suffering from biochemical recurrence has been described thoroughly during the past few years. Several prostate-specific membrane antigen (PSMA)-directed ligands labeled with 111 In, 99m Tc, and 68 Ga have been published; however, limitations regarding availability, short half-life, high costs, and unfavorable high energy might restrict frequent use. This study aims at introducing 67 Ga as a promising radionuclide for radioguided surgery. METHODS: Retrospective analysis was performed on 6 patients with 7 PSMA-positive lymph node metastases. 67 Ga-PSMA I&T (imaging and therapy) was synthesized in-house and intravenously applied according to §13 2b of the German Medicinal Products Act. Radioguided surgery was performed 24 hours after injection of 67 Ga-PSMA I&T using a gamma probe. Patient urine samples were collected. Occupational and waste dosimetry was performed to describe hazards arising from radiation. RESULTS: 67 Ga-PSMA application was tolerated without adverse effects. Five of 7 lymph nodes were detected on 22-hour SPECT/CT in 4 of 6 patients. During surgery, all 7 lymph node metastases were identified by positive gamma probe signal. Relevant accumulation of 67 Ga was observed in lymph node metastases (32.1 ± 15.1 kBq). Histology analysis of near-field lymph node dissection revealed more lymph node metastases than PET/CT (and gamma probe measurements) identified. Waste produced during inpatient stay required decay time of up to 11 days before reaching exemption limits according to German regulations. CONCLUSIONS: Radioguided surgery using 67 Ga-PSMA I&T is a safe and feasible option for patients suffering from biochemical recurrence of prostate cancer. 67 Ga-PSMA I&T was successfully synthesized according to Good Manufacturing Practice guidelines. Radioguided surgery with 67 Ga-PSMA I&T does not lead to relevant radiation burden to urology surgeons and represents a novel interdisciplinary approach in nuclear medicine and urology.
引用
- Winkens T, Berger FP, Foller S, et al. 67 Ga-PSMA I&T for Radioguided Surgery of Lymph Node Metastases in Patients With Biochemical Recurrence of Prostate Cancer. Clin Nucl Med. 2023. PMID: 37145416. doi:10.1097/RLU.0000000000004668
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。